Molecular Partners AG’s Christian Zahnd, CEO, will temporarily be absent from the company due to a medical treatment.
Zurich-Schlieren, March 10, 2015. Molecular Partners AG announced today, that Christian Zahnd, CEO, will temporarily be absent from the company due to a medical treatment, which will begin in the near future.
To allow him to focus entirely on his medical treatment and convalescence the Board of Directors has assigned his duties temporarily to Patrick Amstutz, COO, and Jörn Aldag, Chairman of the Board.
“The Board and employees of Molecular Partners wish Christian an early recovery,” said Jörn Aldag, “We have assembled an impressive and capable leadership team to guide the company’s continued progress. We will be in close contact with him during his absence until his full return.”
Dr. Zahnd noted, “I am grateful for the support and good wishes I have received from the Board and the Molecular Partners team. I look forward to returning with full strength to my responsibilities in the near future.”